Deuterium Incorporation in Medicinal Chemistry

Deuterium labelling has emerged as a powerful tool in drug discovery, offering the potential to enhance metabolic stability, modulate pharmacokinetics and provide critical mechanistic insight. By replacing selected hydrogen atoms with deuterium, researchers can slow oxidative pathways without altering the parent molecule’s pharmacophore, thereby extending half-life and improving safety profiles. Beyond therapeutic optimisation, deuterated compounds serve as indispensable tracers in mass spectrometry, autoradiography and receptor-binding studies. The strategies for incorporating deuterium range from traditional acid- or base-mediated hydrogen-deuterium exchange to modern catalyst-driven and photochemical methods. Recent advances have sought to combine high selectivity with mild conditions and sustainability, employing electrochemical, enzymatic and heterogeneous catalytic platforms. Together, these developments have transformed late-stage functionalisation and enabled kilogram-scale production of deuterated drug candidates, underlining global interest in routine and scalable isotope-labelling technologies.

Research from Nature Portfolio

In an electrochemical approach, simple pyridine and quinolone derivatives have been site-selectively deuterated at C4 under ambient, metal-free conditions using D₂O. The process proceeds via in situ generation of key pyridinium intermediates revealed by cyclic voltammetry, delivering high deuterium incorporation across diverse N-heterocycles without added acid or base. A nanostructured iron catalyst prepared from cellulose and iron salts enables kilogram-scale, selective C–H deuteration of (hetero)arenes under hydrogen pressure. This air- and water-stable material affords anilines, phenols, indoles and other heterocycles selectively labelled with minimal waste, representing a practical route to large-volume production of deuterated active ingredients. Complementing two-electron processes, a visible-light driven, peptide-derived thiol catalyst mediates one-electron deuterium-atom transfer for enantioselective radical deuteration at non-benzylic positions. This metal-free platform achieves high stereocontrol and D-incorporation at exocyclic olefins, expanding the scope of asymmetric isotopic labelling in pharmaceutical scaffolds.

Deuterium Incorporation in Medicinal Chemistry publication trend

The graph below shows the total number of articles in deuterium incorporation in medicinal chemistry across all publications each year (not limited to Nature Index journals).

Technical terms

Isotope labelling: The incorporation of isotopes into molecules to trace or modify their properties in chemical or biological studies.

Hydrogen–deuterium exchange (HIE): A reaction in which a hydrogen atom in an organic substrate is replaced by deuterium, often catalysed by transition metals or photocatalysts.

Photoredox catalysis: Activation of substrates using visible light and photocatalysts to induce single-electron transfer and radical pathways.

Regioselectivity: The preference for a chemical reaction to occur at one location over another within a molecule.

Late-stage functionalisation: The modification of complex molecules at a late point in a synthetic sequence to install or exchange functional groups without disturbing existing motifs.

Hydrogen atom transfer (HAT): A process in which a hydrogen radical (H•) is transferred between a substrate and a catalyst or reagent, enabling selective C–H activation.

References

1. Electrochemical C−H deuteration of pyridine derivatives with D2O. Nature Communications (2024).
2. Formyl-selective deuteration of aldehydes with D 2 O via synergistic organic and photoredox catalysis. Chemical Science (2020).
3. Highly Selective Directed Iridium‐Catalyzed Hydrogen Isotope Exchange Reactions of Aliphatic Amides. Angewandte Chemie International Edition (2018).
4. Visible light driven deuteration of formyl C–H and hydridic C(sp 3 )–H bonds in feedstock chemicals and pharmaceutical molecules. Chemical Science (2020).
5. Scalable and selective deuteration of (hetero)arenes. Nature Chemistry (2022).
6. Visible-light mediated catalytic asymmetric radical deuteration at non-benzylic positions. Nature Communications (2022).